apremilast (Otezla®)

SELF ADMINISTRATION - ORAL

Indications for Prior Authorization:

  • Psoriatic Arthritis
  • Plaque Psoriasis

Otezla is a preferred agent for the treatment of the following indication(s) when all criteria below are met for specific indication(s):

  • Plaque Psoriasis

Patients must meet the following criteria for the indications above:

Psoriatic Arthritis

  • Diagnosis of active psoriatic arthritis AND
  • Failure of or clinically significant adverse effects to methotrexate, AND
  • The patient has tried and failed at least one preferred agent (e.g., Humira, Enbrel)

Plaque Psoriasis

  • Diagnosis of moderate to severe plaque psoriasis confirmed by a dermatologist or rheumatologist ; affects 10% or more of the body; psoriasis involves hands, feet, head, and neck or genitalia AND
  • Prescribed by a Dermatologist or Rheumatologist AND
  • Failure or clinically significant adverse effects to methotrexate either alone or in combination OR
  • If methotrexate is contraindicated, failure or clinically significant adverse effects to PUVA, UVB, cyclosporin, or acitretin

The Following Conditions Do Not Meet the Criteria for Use as Established by the WHA P & T Committee:

  • All non-FDA approved uses not listed in the approved indications

Dosing:

  • Titrate to recommended dose of 30 mg PO BID according to the following schedule:
  • Day 1:  10 mg PO AM
  • Day 2:  10mg PO AM and PM
  • Day 3:  10mg PO AM and 20 mg PO PM
  • Day 4:  20mg PO AM and PM
  • Day 5:  20mg PO AM and 30 mg PO PM
  • Day 6 and thereafter:  30 mg PO BID

Approval:

  • Initial approval 4 months to assess patient's response
  • Renewal for one year if patient has clinical response

 

Last review date: July 21, 2016

The site you are transferring to is not hosted by WHA. WHA's Terms of Use and internet Privacy Practices do not apply to your use of this linked site. Please review the policies on privacy and terms of use for the linked site. WHA does not control the accuracy, completeness, or timeliness of the content on the linked site.

Press Esc to cancel

El sitio Web al que está siendo transferido no es provisto por WHA. Las Condiciones de Uso y las Prácticas de Privacidad en Internet de WHA no se aplican a este sitio Web asociado que usted está usando. Revise las políticas sobre la privacidad y condiciones de uso de este sitio Web asociado. WHA no tiene control sobre la exactitud, la totalidad o la actualidad del contenido del sitio Web asociado. WHA no puede garantizar que los servicios de traducción de idiomas estarán disponibles en el sitio vinculado.

Presione «Esc» para cancelar